From: Chryseobacterium indologenes in a woman with acute leukemia in Senegal: a case report
Antibiotics | MIC (μg/mL) | IZD (mm) | Breakpoint (S) | Categorization | |
---|---|---|---|---|---|
μg/mL | mm | ||||
Ampicillin | ≥256 | 0 | ≤16 | ≥22 | Resistant |
Piperacillin | 16 | 20 | ≤16 | ≥18 | Susceptible |
Ticarcillin | ≥256 | 0 | ≤16 | ≥22 | Resistant |
Temocillin | ≥256 | 0 | ≤16 | ≥22 | Resistant |
Cephalothin | ≥256 | 0 | ≤16 | ≥22 | Resistant |
Cefuroxime | ≥256 | 0 | ≤16 | ≥22 | Resistant |
Cefotaxime | 32 | 8 | ≤16 | ≥22 | Resistant |
Ceftazidime | 4 | 25 | ≤08 | ≥19 | Susceptible |
Ceftriaxone | 32 | 8 | ≤16 | ≥22 | Resistant |
Cefepime | 4 | 28 | ≤08 | ≥19 | Susceptible |
Cefotetan | ≥32 | 6 | ≤16 | ≥22 | Resistant |
Imipenem | ≥32 | 6 | ≤04 | ≥22 | Resistant |
Meropenem | 32 | 6 | ≤02 | ≥22 | Resistant |
Ertapenem | ≥32 | 6 | ≤02 | ≥22 | Resistant |
Aztreonam | ≥32 | 8 | ≤01 | ≥27 | Resistant |
Trimethoprim-sulfamethoxazole | ≤0.25 | 22 | ≤2 | ≥16 | Susceptible |
Nalidixic acid | ≤2 | 28 | ≤08 | ≥20 | Susceptible |
Gentamicin | ND | 4 | ND | ≥16 | Resistant |
Amikacin | ND | 0 | ND | ≥17 | Resistant |
Tobramycin | ND | 0 | ND | ≥16 | Resistant |
Colistin | ND | 0 | ND | – | Resistant |